• English
    • español
    • português (Brasil)
  • English 
    • English
    • español
    • português (Brasil)
  • Login
Search 
  •   COVID-19
  • Resources in English
  • Search
  •   COVID-19
  • Resources in English
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

Now showing items 1-10 of 953

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
  • Thumbnail

    Facing Covid-19 in Italy — Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line 

    Rosenbaum L. (2020-03-18)
  • Thumbnail

    Recommendations for Election Polling Locations, Interim guidance to prevent spread of coronavirus disease 2019 

    United States. Centers for Disease Control and Prevention (2020-03-09)
    Background: There is much to learn about the novel coronavirus that causes coronavirus disease 2019 (COVID-19). Based on what is currently known about this virus and similar coronaviruses, spread from person-to-person ...
  • Thumbnail

    Guidance for Travellers coming to Guyana 

    Guyana. Ministry of Public Health
  • Thumbnail

    Lopinave/Litonawe (LPV/r) reduced mortality in studies of SARS and MERS: uncertain if it is effective for patients with COVID-19 

    Allen, Claire (2020-03-20)
    What is this? Like COVID-19, severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) are acute respiratory diseases caused by a coronavirus. Antiviral therapy with Lopinave/Litonawe (LPV/r) ...
  • Thumbnail

    Lianhuaqingwen Exerts Anti-Viral and Anti-Inflammatory Activity Against Novel Coronavirus (SARS-CoV-2) 

    Runfeng, L, et al. State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong (2020-03-20)
    Purpose: Lianhuaqingwen (LH) as traditional Chinese medicine (TCM) formula has been used to treat influenza and exerted broad-spectrum antiviral effects on a series of influenza viruses and immune regulatory effects [1]. ...
  • Thumbnail

    Clinical Characteristics of Children With Coronavirus Disease 2019 in Hubei, China 

    Zheng, F, et al. Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan (2020-03-24)
    Since December 2019, COVID-19 has occurred unexpectedly and emerged as a health problem worldwide. Despite the rapidly increasing number of cases in subsequent weeks, the clinical characteristics of pediatric cases are ...
  • Thumbnail

    Identifying Locations with Possible Undetected Imported Severe Acute Respiratory Syndrome Coronavirus 2 Cases by Using Importation Predictions 

    De Salazar, PM, et al. Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA (2020-03-24)
    Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection exported from mainland China could lead to self-sustained outbreaks in other countries. By February 2020, several countries were reporting ...
  • Thumbnail

    2019-ncov's epidemic in middle province of northern Italy: impact, logistic & strategy in the first line hospital 

    Gagliano, A, et al. Department of Surgery, Complex unit of General & Thoracic Surgery, Lodi, Italy. (2020-03-24)
    The novel coronavirus (2019-nCoV) began in China in early December 2019 and rapidly has spread to many countries around the globe, with the number of confirmed cases increasing every day. An epidemic has been recorded since ...
  • Thumbnail

    Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China 

    Shaobo, Shi; Qin, Mu; Shen, Bo (2020-03-25)
    Importance Coronavirus disease 2019 (COVID-19) has resulted in considerable morbidity and mortality worldwide since December 2019. However, information on cardiac injury in patients affected by COVID-19 is limited. Objective ...
  • Thumbnail

    Investigational COVID-19 Convalescent Plasma - Emergency INDs 

    United States. Food and Drug Administration (2020-03-24)
    The Food and Drug Administration (FDA or Agency) plays a critical role in protecting the United States from public health threats including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to doing ...
  • 1
  • 2
  • 3
  • 4
  • . . .
  • 96

Discover

CategoryClinical characterization and management (294)Infection prevention and control, including health care workers protection (231)Epidemiology and epidemiological studies (148)Candidate therapeutics RD (142)Virus: natural history, transmission and diagnostics (110)Public Health Interventions (72)Health systems and services (53)Social sciences in the response (25)Ethical considerations for research (18)Operation readiness, surge capacity (14)... View MoreLanguageEnglish (941)Español (1)Other (1)Português (1)TypePublished Article (691)Other publications (84)Research protocol information (57)WHO / PAHO Guidance (44)WHO/PAHO Guidance (44)Other public health institution guidance (29)Journal Article (4)CountryOthers (556)Global (WHO/OMS) (284)Regional, Americas (PAHO/OPS) (68)Canada (17)United States (15)Brasil (3)China (2)Guyana (2)Antigua and Barbuda (1)Belize (1)... View MoreAuthorPan American Health Organization (62)World Health Organization (31)Allen, Claire (30)Government of Canada (16)Evidence Aid (7)BMJ Best Practice (5)Heneghan, Carl (5)Guyana. Ministry of Public Health (3)Alizadeh, Fahimeh (2)Aronson, Jeffrey K. (2)... View MoreSubject
Coronavirus (953)
COVID-19 (950)Infectious Diseases (670)Coronavirus Infections (285)Betacoronavirus (163)SARS-CoV-2 (131)Pandemics (74)SARS-CoV (71)Infecctious Diseases (65)Mortality (61)... View MoreDate Issued2020 - 2021 (935)2010 - 2019 (15)2009 - 2009 (1)

Browse

AllCommunities & CollectionsBy Issue DateAuthorsTitlesCategorySubjectsThis CommunityBy Issue DateAuthorsTitlesCategorySubjects

My Account

LoginRegister

Pan American Health Organization
World Health Organization. Regional Office for the Americas
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America

Content Disclaimer (Important notes about the material)

Links

  • WHO International Clinical Trial Registry Platform (ICTRP)
  • WHO Coronavirus disease R&D Blueprint
  • WHO Database of Publications on Coronavirus Disease
  • PAHO Coronavirus Disease
  • PAHO/BIREME Windows of Knowledge COVID-19
  • Evidence aid Coronavirus (COVID-19) resources

  • PAHO Digital Library (IRIS PAHO)
  • Virtual Health Library (VHL)
  • Global Index Medicus (GIM)